ARTICLE | Company News
Seattle Genetics, GlaxoSmithKline deal
January 4, 2010 8:00 AM UTC
GlaxoSmithKline received exclusive, worldwide rights to use Seattle Genetics' antibody-drug conjugate (ADC) technology with multiple antigens to be named by GSK. Seattle Genetics will receive $12 mill...